Development and evaluation of calcium alginate beads prepared by sequential and simultaneous methods

ARTICLE

Development and evaluation of calcium alginate beads prepared by sequential and simultaneous methods

Sanchita Mandal; S. Senthil Kumar; Balakrishnam Krishnamoorthy; Sanat Kumar Basu^*

Division of Pharmaceutics, Department of Pharmaceutical Technology, Jadavpur University

ABSTRACT

The objective of this study was to develop a sustained release dosage form of Trimetazidine dihydrochloride (TMZ) using a natural polymeric carrier prepared in a completely aqueous environment. TMZ was entrapped in calcium alginate beads prepared with sodium alginate by the ionotropic gelation method using calcium chloride as a crosslinking agent. The drug was incorporated either into preformed calcium alginate gel beads (sequential method) or incorporated simultaneously during the gelation stage (simultaneous method). The beads were evaluated for particle size and surface morphology using optical microscopy and SEM, respectively. Beads produced by the sequential method had higher drug entrapment. Drug entrapment in the sequential method was higher with increased CaCl₂ and polymer concentration but lower with increased drug concentration. In the simultaneous method, drug entrapment was higher when polymer and drug concentration were increased and also rose to a certain extent with increase in CaCl₂ concentration, where further increase resulted in lower drug loading. FTIR studies revealed that there is no interaction between drug and CaCl₂. XRD studies showed that the crystalline drug changed to an amorphous state after formulation. Release characteristics of the TMZ loaded calcium alginate beads were studied in enzyme-free simulated gastric and intestinal fluid.

Uniterms: Sodium alginate. Calcium alginate beads. Trimetazidine dihydrochloride. Ionotropic gelation.

RESUMO

O objetivo deste estudo foi desenvolver forma de liberação controlada de dicloridrato de trimetazidina (TMZ) utilizando transportador plomérico natural em ambiente completamente aquoso. A TMZ foi presa em pérolas de alginato de cálcio preparadas com alginato de sódio pelo método de gelatinização ionotrópica, usando cloreto de cálcio como agente de formação de ligações cruzadas. O fármaco foi incorporado nas pérolas de gel de alginato de cálcio (método sequencial) ou incorporado, simultaneamente, durante o estágio de gelificação (método simultâneo). As pérolas foram avaliadas quanto ao tamanho das partículas e morfologia da superfície utilizando microscopia óptica de SEM, respectivamente. As pérolas produzidas pelo método sequencial apresentaram maior capacidade de inclusão. No método sequencial, a inclusão de fármaco foi maior com o aumento de CaCl₂ e da concentração do plímero, mas menor com o aumento da concentração de fármaco. No método simultâneo, a inclusão de fármaco foi mais alta quando as concentrações de fármaco e plímero foram aumentadas e, também, atingiram certa extensão com aumento na concentração de CaCl₂, cujo aumento posterior resultou em carga menor de fármaco. Estudos de FTIR revelaram que não há interação entre fármaco e CaCl₂. Estudos de XRD mostraram que o fármaco mudou do estado cristalino para o amorfo após a formulação. As características de liberação de TMZ das pérolas carregadas com alginato de cálcio foram estudadas em fluidos simulados, gástrico e intestinal, livres de enzima.

Uniterms: Alginato de sódio. Beads de alginato de cálcio. Dicloridrato de trimetazidina. Gelatinização ionotrópica.

INTRODUCTION

TMZ, 1-[(2,3,4-tri-methoxyphenyl) methyl] piperazine is a lesser known member of a new class of antianginal drug (Manchanda, Krishnaswami, 1997). Unlike all the conventional antianginal agents, which affect haemodynamic determinants of the myocardial oxygen supply-demand balance, TMZ partly prevents intercellular metabolic changes such as depletion of adenosine triphosphate (ATP) and phosphocreatine, accumulation of protons, and toxic free radical generation which results from ischemia and reperfusion in the myocardium (Harpey et al., 1989). It selectively inhibit long chain 3-keto acyl-co-enzyme A (CoA) thiolase (3-KAT), which catalyses the terminal step of fatty acid beta-oxidation (Stanley, 2002).

Sodium alginate, a hydrophilic biopolymer obtained from brown seaweeds has been found to be highly promising with respect to drug delivery because of its high biological safety (Sriamornsak et al., 2007). Chemically, it is a polysaccharide composed of varying proportions of D-mannuronic acid (M) and L-guluronic acid (G) residues which are arranged in MM or GG blocks interspersed with MG blocks (Aslani, Kennedy, 1996). In addition to its use as a thickening, gel forming and colloidal stabilizing agent in the food and beverage industries, it is also used as a binder in tablet formulation (Liew et al., 2006). Its unique property of forming water insoluble calcium alginate gel through ionotropic gelation with Ca⁺² ions under simple and mild conditions has made it possible to encapsulate both macromolecular agents (Polk et al., 1994; Kikuchi et al., 1996; Bowersock et al., 1999) and low molecular weight therapeutic agents (Cui et al., 2001; Gonzalez-Rodriguez et al., 2002; Halder et al., 2005). The current uses of alginate-based devices are mainly related to encapsulation of various classes of therapeutic agents (El-Zatahry et al., 2006, Shishu et al., 2007; Mandal et al., 2010).

In this study, TMZ was incorporated into calcium alginate beads by sequential and simultaneous methods. The effect of polymer and CaCl₂ concentration and that of TMZ concentration on drug entrapment (drug loading) and drug release characteristics were studied. The drug-loaded beads were also characterized using different techniques.

MATERIAL AND METHOD

Trimetazidine dihydrochloride BP (Sun Pharmaceuticals Pvt. Ltd., Vadodora, India ), Sodium alginate (Fluka) 90 cps (1% w/v solution in water at 25 °C), and Calcium chloride dihydrate (E. Merck, India) were used. All other reagents were of analytical grade.

Preparation of beads

For bead formation, 50 mL of a 2-2.5% w/v aqueous solution of sodium alginate was introduced dropwise from a glass syringe with a size-22 needle into 100 mL of an aqueous calcium chloride solution being stirred at 400 rpm. The concentration of CaCl₂ in the solution ranged from 1% w/v to 3% w/v. The stirring was continued for one hour and the calcium alginate beads were harvested by filtration, washed with distilled water, and air dried overnight.

Drug loading was carried out by two methods, designated as the sequential method and the simultaneous method. In the sequential method, calcium alginate beads were prepared as described in the previous paragraph. The wet beads were then immersed and stirred for 1hr in a solution containing TMZ (concentration ranging from 2-3 % w/v), filtered and washed with distilled water. TMZ-loaded calcium alginate beads were obtained by subsequent drying. In the simultaneous method, the gelation of beads by calcium ions occurred simultaneously with the drug loading into the beads. The sodium alginate solution was introduced dropwise into CaCl₂ solutions (concentration ranging from 1-3 %w/v) which also contained TMZ (concentration ranging from 2-3% w/v). After 1hr of interaction, the beads were removed from the counter ion solution. The drug loaded beads were washed and dried in a manner similar to that of blank beads (beads without drug).

Determination of drug content

For determination of drug content, 10 mg of beads were placed in 100 mL of double distilled water for 24 h. The filtered solution was measured for TMZ content using a UV spectrophotometer (GENESYS 10 UV Spectrophotometer,Thermo Corporation USA) at 202 nm. Drug content was computed using a calibration curve (R² = 0.9998) prepared using solutions with concentrations of 1-6 μg/mL of TMZ.

The drug loading capacity of the beads was then computed according to the following equation:

Particle size distribution

The particle size determination of TMZ-loaded calcium alginate beads was carried out using an optical microscope along with a stage micrometer having an accuracy of 0.01 mm. A suspension of beads in liquid paraffin was prepared in a beaker and then one drop of this was dropped on a clean glass slide and covered with a cover slip. The average sizes of 100 beads were determined for each formulation using the calibration factor. The average diameter of the beads was calculated using the following formula:

X = Average particle diameter, X_i = Individual diameter of beads, N = Number of beads.

Scanning electron microscopy

The surface morphology of drug-loaded beads obtained from various percentages of polymer, CaCl₂ and drug were studied by using a scanning electron microscope (model JEOL JSM6360, Japan). The beads were mounted on an appropriate stub and then coated with carbon and gold (100 and 50 Å thickness respectively) sputter module in a vacuum evaporator in an argon atmosphere. The coated samples were then observed under a scanning electron microscope operated at 15 KV.

Fourier transform infra red analysis

The IR analysis of pure drug, polymer, and drug-loaded beads prepared by both the methods were analyzed with FTIR spectrophotometer (Shimadzu FTIR-8400, Japan). All the samples were crushed with potassium bromide to get pellets at 600kg cm^-2. Spectral scanning was done in the range of 400-4000 cm^-1.

X-ray diffraction study

To understand the crystalline state of the drug in the polymer matrix, the X-ray diffraction pattern of drug-loaded beads was performed and compared with that of pure drug. Powder forms of the samples were exposed to Cu radiation (30kv × 15mA) in a wide-angle X-ray diffractometer (Miniflex gonio Meter, Japan). The instrument was operated in continuous mode in increments of 1°/min and scanned over a 2θ range of 10 to 90°.

In vitro drug release study

In vitro drug release studies were carried out in triplicate using a USP II tablet dissolution test apparatus (model TDP-06P, Electro Lab, Mumbai, India) at 37±0.5 ºC and 100 rpm. The beads of each formulation were placed in enzyme-free simulated gastric fluid (900 mL, 0.1N HCl, pH 1.2) for the first 2h and then in enzyme-free simulated intestinal fluid (900ml, Phosphate buffer solution, pH 6.8) for 7 h. A 5 mL aliquot of the dissolution fluid was withdrawn at regular intervals of time and replaced immediately with the same volume of fresh media. The aliquots, following suitable dilution, were analyzed for drug content using a spectrophotometer at 202 nm.

RESULTS AND DISCUSSION

In this investigation, a simple and inexpensive method was developed for the preparation of calcium alginate beads. Crosslinking of sodium alginate was done using CaCl₂ and TMZ was loaded in the same. The various compositions of the formulation variables used for the present study are given in Table I.

Particle size was in the range of 1005 μm to 1075 μm for the beads obtained using the sequential method, and 1057 μm to 1207 μm for those from the simultaneous method (Table 2). The particle size of the beads prepared by the simultaneous method decreased with higher CaCl₂ concentrations.

Scanning electron microscopy

The surface morphology of the prepared beads was studied by scanning electron microscopy (SEM) and the SEM photographs are depicted in Figure 1.

SEM photographs of the blank beads compared with drug loaded beads show a difference in surface morphology for both the sequential and simultaneous method. Smoothness increased when drug was loaded in the beads.

The SEM photographs of the drug-loaded beads (Figure 1[A]) show that the drug is dispersed in the polymeric matrix without having any coat, which further confirms that this system is a polymeric matrix system for beads prepared by both sequential and simultaneous methods.

The SEM photographs presented in Figure 1[B] also show differences in surface morphology of the prepared beads before and after the completion of in-vitro dissolution study for both the sequential and simultaneous methods. The surface of beads after dissolution was rougher than before dissolution.

Drug loading

Drug loading was found to be in the range of 42-62% for beads prepared by the sequential method and 39-58% for the simultaneous method. Drug loading was found to be directly proportional to polymer concentration (El-Kamel et al., 2003) in both the methods. The effect of crosslinking agent and drug concentration on drug loading however, was different in both methods.

Higher loading efficiency was obtained as the concentration of alginate increased. This may be attributed to the greater availability of active calcium binding sites in the polymeric chains and consequently, the greater degree of crosslinking as the quantity of sodium alginate increased (Yotsuyanagi et al., 1987). For the sequential method, batch C3 had the highest drug loading (62%). The use of drug concentrations greater than 2% w/v did not result in further enhancement of drug loading.

It was observed that the efficiency of loading TMZ into the calcium alginate beads by the simultaneous method was lower than by the sequential method (Lim, Wan, 1997). For the simultaneous method, batch B4 had the highest drug loading (58%). When the drug loading was carried out by the simultaneous method with the gelation of alginate by Ca⁺², the counter ion solution contained both the drug molecule and CaCl₂. The drug molecules and Ca⁺² ions diffuse in the same direction, from the solution into the sodium alginate solution, and competed simultaneously for common binding sites along the alginate chains. The amount of associated Ca⁺² ions (and the drug molecules) in the beads was a function of the concentration ratio of CaCl₂: TMZ in the solution.

Increase in CaCl₂ concentration from 1 to 3% and polymer concentration from 2 to 2.5% resulted in an increase in the drug entrapment from 53% to 62%, and from 45% to 62%, respectively for the sequential method. Drug entrapment decreased from 62% to 42% when the drug concentration was increased from 2 -3% for the same.

Similarly, in the simultaneous method increase in drug entrapment from 47% to 58%, from 52% to 58% and from 55% to 58% was observed for corresponding changes in the CaCl₂, polymer and drug concentration, respectively.

Fourier transformed infra red analysis

FTIR spectral data were used to confirm the chemical stability of Trimetazidine in alginate beads. FTIR spectra of pure drug, sodium alginate, TMZ-loaded calcium alginate beads prepared by sequential and simultaneous method were compared in Figure 2. FTIR spectra of TMZ show the characteristic bands of -OH stretching, -CH stretching, >C=O stretching, C-H bending and C-O-C stretching at 3440, 2995, 1605, 1417, and 1101 cm^-1, respectively. The spectra obtained from drug-loaded beads prepared by both the methods, indicate the presence of the characteristic bands of the drug at almost the same wave number.

X-ray diffraction study

In order to confirm the physical state of the drug in the beads, data for the X-ray diffraction studies of the pure drug, polymer, empty beads and beads containing the drug is shown in Figure 3. No characteristic XRD pattern was observed in the case of drug-loaded beads. Thus, from the X-ray diffraction data of the drug-loaded beads, it can be inferred that the drug was not present in the crystalline state in the bead matrix but was in the amorphous state. This clearly indicated that changes in the crystalline state of the drug occurred during the preparation of the beads by this ionotropic gelation method.

In-vitro drug release

The release profile of TMZ in enzyme-free simulated gastric fluid (SGF) followed by enzyme-free simulated intestinal fluid (SIF) from the calcium alginate beads prepared under different conditions are shown in Figures 4-6. The drug release from the alginate beads depends on the penetration of the dissolution medium into the beads, swelling and dissolution of alginate matrix, and the dissolution of the drug subsequent to leaching through the swollen matrix. In SGF alginate beads prepared by the sequential method, TMZ releases about 30-40 % drug in the first 2 h. The rest of the drug then releases in the SIF, continuing for up to 9 h whereby it releases 82-89% of the drug. It was found that drug release is accompanied by a burst release which may be due to the highly water soluble nature of the drug.

Effect of polymer

To study the effect of sodium alginate concentration on TMZ release, two different concentrations, 2 and 2.5% w/v were used. Figure 4 shows the influence of the concentration of sodium alginate solution on Trimetazidine release behavior from calcium alginate-loaded beads prepared by the sequential and simultaneous methods. Lower concentrations of sodium alginate led to faster drug release, with 89.05±0.178% of drug release within 9 h using the sequential method. Increase in alginate concentration slowed the release rate. Thus, the results indicate that drug release was directly proportional to sodium alginate concentration (Yotsuyanagi et al., 1987; Basu, Rajendran, 2008). The principal gelation or cross-linking of sodium alginate with CaCl₂ is based on the tight junction between the guluronic acid residues (Rajinikanth et al., 2003). The number of the apparent cross-linking points formed within increases with increasing alginate concentration in the formulation. This can be correlated with the particle size studies where, as alginate concentration increased, particle size decreased, due to the formation of more a rigid and compact matrix, consequently retarding TMZ release.

In the case of TMZ-loaded calcium alginate beads prepared by the simultaneous method, similar behavior was also observed.

Effect of CaCl₂

The release behavior of calcium alginate beads prepared by the sequential method with different concentrations of CaCl₂ (1-3% w/v) is indicated in Figure 5. Drug release was sustained from 38% to 30% in SGF for 2 h, and 89% to 82% in SIF fluid up to 9 h with increasing CaCl₂ concentration. Thus, in the sequential method, as the concentration of crosslinking agent increased, drug release decreased (El-Zatahry et al. 2006). Beads prepared with 3% w/v CaCl₂ showed the most sustained release effect due to more crosslinking resulting in the formation of a more rigid gel network and hence greater sustained release characteristics. It was confirmed by particle size studies, where the size of the beads was found to be smaller as the concentration of crosslinking agent increased (El-Kamel et al., 2003). It was also evident from the literature (Rajinikanth et al., 2003) that diffusion of drug from alginate matrix decreased as the concentration of CaCl₂ solution increased in the sequential method, probably due to greater cross-linking with sodium alginate.

In the simultaneous method, TMZ release was sustained from 30% to 37% in SGF for 2h, and from 93% to 82% in SIF up to 9 h (Figure 5). But in case of the simultaneous method, 3% crosslinking agent did not show the highest sustained effect. This may be due to the low drug loading (Lim et al., 1997).

Effect of drug concentration

It was found that drug releases within the 1^st hour were indicative of a burst effect. This could be attributed to the highly water soluble nature of the drug. A similar result was found by Ray et al., (Ray et al., 2008) during preparation of diltiazem resin complex-loaded carboxymethyl xanthan beads.

The effect of drug concentration during in-vitro drug release study does not affect the drug release from the calcium alginate beads. The drug concentration ranged from 2 to 3% w/v to study the effect of drug release shown in Figure 6. TMZ release from beads prepared by the sequential method (batch C3), which contained 2% w/v TMZ, shows a more sustained effect with drug loading of about 62%.

However, in the case of the simultaneous method (batch B4), which contains 3% w/v drug, a more sustained effect with drug loading of about 58% was evident. Drug release was found to be highly dependent on drug loading.

CONCLUSION

Trimetazidine was entrapped in calcium alginate beads prepared with sodium alginate by the ionotropic gelation method, using calcium chloride as a crosslinking agent. The drug was incorporated by two methods, sequential and simultaneous methods. Beads produced by the former method had higher drug entrapment. The beads were evaluated for drug entrapment, particle size and release characteristics in enzyme-free simulated gastric and simulated intestinal fluid. The drug entrapment in the sequential method increases with increased CaCl₂ and polymer concentration but decreased with higher drug concentration. In the simultaneous method, drug entrapment was higher with polymer and drug concentration increase and rose to a certain extent with increase in the concentration of CaCl₂ and after further increase it decreased. Drug release was directly proportional to the polymer concentration for the drug-loaded beads prepared by both the methods. Increase in CaCl₂ concentration retarded the drug release in the sequential method whereas for the simultaneous method the retardation in drug release occurred up to a certain concentration of CaCl₂. The drug concentration exhibits a drug-loading dependent effect on the release behavior in both the methods.

ACKNOWLEDGEMENT

The authors would like to thank Sun Pharmaceuticals Pvt Ltd, Vadodora, India for supplying Trimetazidine dihydrochloride as a gift sample.

Received for publication on 23^th November 2009.

Accepted for publication on 17^th March 2010.

• ASLANI, P.; KENNEDY, R.A. Studies on diffusion in alginate gels, I. Effects of cross-linking with calcium or zinc ions on diffusion of acetaminophen. J. Control. Rel, v.42, p.75-82, 1996.
• BASU, S.K.; RAJENDRAN, A. Studies in the development of neteglinide loaded calcium alginate and chitosan coated calcium alginate beads. Chem. Pharm. Bull., v.56, p.1077-1084, 2008.
• BOWERSOCK, T.L; HOGE.; ESCH, H.; SUCKOW, M.; GUIMOND, P.; MARTIN, S.; BORIE, D. Oral vaccination of animals with antigens encapsulated in alginate Microspheres. Vaccine, v.17, p.1804-1811, 1999.
• CUI, J.H.; GOH, J.S.; PARK, S.Y.; KIM, P.H.; LE, B.J. Preparation and physical characterization of alginate microparticles using air atomization method. Drug. Dev. Ind. Pharm, v.27, p.309-319, 2001.
• EL-ZATAHRY, A.A.; SOLIMAN, E.A.; HASSAN, E.A.; MOHY ELDIN, M.S. Preparation and in vitro release of theophylline loaded sodium alginate microspheres. In: ASTF. SCIENTIFIC RESEARCH OUTLOOK 2006 CONFERENCE. Paper n.155, p.1-20, 2006. <http://www.astf.net/sro/sro4/third%20scope%20priorities%20of%20scientific%20research%20and%20specialized%20 domains%20in%20science/Scientific%20areas%20of%20priorities/New%20Material/Accepted/155P.pdf>. Accessed on: 28^th feb. 2006
• EL-KAMEL, A.H.; AL-GOHARY, O.M.; HOSNY, E.A. Alginate-diltiazem hydrochloride beads: optimization of formulations factors, in vitro and in vivo availability. J. Microencapsul., v.20, p.211-225, 2003.
• GONZALEZ-RODRIGUEZ, M.L.; HOLGADO, M.A.; SANCHEZ-LAFUENTE, C.; RABASCO, A.M.; FINI, A. Alginate/Chitosan particulate systems for sodium Diclofenac release. Int. J. Pharm., v.232, p.225-234, 2002.
• HALDER, A.; MAITI, S.; SA, B. Entrapment efficiency and release characteristics of polyethyleneimine-treated or-untreated calcium alginate beads loaded with propranolol-resign complex. Int. J. Pharm., v.302, p.84-94, 2005.
• HARPEY, C.; CLAUSER, P.; LABRID, C.; FRYRIA, J-L.; POIRIER, J-P. Trimetazidine, a cellular anti-ischemic agent. Cardiovasc. Drugs Rev, v.6, p.292-312, 1988.
• KIKUCHI, A.; KAWABUCHI, M.; SUGIHARA, M.; SAKURAI, Y.; OKANO, T. Controlled release of macromolecular dextran from calcium-alginate gel beads. Control. Rel. Bioact. Mater, v.23, p.737-738, 1996.
• LIEW, C.V.; CHAN, L.W.; CHING, A.L.; HENG, P.W.S. Evaluation of Sodium alginate as drug release modifier in matrix tablets. Int. J. Pharm., v.309, p.25-37, 2006.
• LIM, L.Y.; WAN, S.C. Propanolol hydrochloride binding in calcium alginate beads. Drug Dev. Ind. Pharm., v.23, p.973-980, 1997.
• MANCHANDA, S.C.; KRISHNASWAMI, S. Combination treatment with Trimetazidine and diltiazem in stable angina pectoris. Heart, v.78, p.353-357, 1997.
• MANDAL, B.; ALEXANDER, K.S.; RIGA, A.T.Evaluation of the drug-polymer interaction in calcium alginate beads containing diflunisal. Pharmazie, v.65, p.106-109, 2010.
• POLK, A.; AMSDEN, B.; YAO, K.D.; PENG, T.; GOOSEN, M.F.A. Controlled release of albumin from chitosan-alginate microcapsules. J. Pharm. Sci., v.83, p.178-185, 1994.
• RAJINIKANTH, P.S.; SANKAR, C.; MISHRA, B. Sodium alginate microsphere of metoprolol tartarate for intranasal systemic delivery: development and evaluation. Drug Deliv., v.10, p.21-28, 2003.
• RAY, S.; MAITI, S.; SA, B. Preliminary investigation on the development of diltiazem resign complex loaded carboxymethyl xanthan beads. AAPS PharmSciTech., v.9, p.295-299, 2008.
• SHISHU, GUPTA, N.; AGGARWAL, N. Stomach-specific drug delivery of 5-fluorouracil using floating alginate beads. AAPS PharmSciTech., v.8, p.E1-E7, 2007.
• STANLEY, W.C. Partial inhibition of cardiac fatty acid oxidation for the treatment of chronic stable angina. Expert Opin. Invest. Drugs, v.11, p.1-15, 2002.
• SRIAMORNSAK, P.; THIRAWONG, N.; KORKERD, K. Swelling, erosion and release behaviour of alginate-based matrix tablets. Eur. J. Pharm. Biopharm., v.66, p.435-450, 2007.
• YOTSUYANAGI, T.; OHKUBO, T.; OHHASHI, T.; IKEDA, K. Calcium-induced gelatin of alginic acid and pH-sensitive reswelling of dried gels. Chem. Pharm. Bull., v.35, p.1555-1563, 1987.

Publication Dates

• Publication in this collection
  10 Feb 2011
• Date of issue
  Dec 2010

History

• Received
  23 Nov 2009
• Accepted
  17 Mar 2010